Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors

Clinical trial NCT04771520 · RECRUITING

Trial details

NCT number: NCT04771520
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 Locally Advanced Malignant Solid Neoplasm Locally Advanced Melanoma Locally Advanced Primary Malignant Central Nervous System Neoplasm Locally Advanced Sarcoma Metastatic Malignant Solid Neoplasm Metastatic Melanoma Metastatic Primary Malignant Central Nervous System Neoplasm Metastatic Sarcoma

Start date: 2021-01-20
Primary completion: 2026-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.